Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 7,871 | 22,499 | 9,734 | 8,360 | 6,355 |
| Gross Profit | 7,871 | 22,499 | 9,734 | 8,360 | 6,355 |
| Operating Expenses | 90,070 | 54,677 | 45,739 | 34,512 | 25,425 |
| Operating Income | -82,199 | -32,178 | -36,005 | -26,152 | -19,070 |
| Other Income | 7,391 | 345 | 1,473 | 660 | 946 |
| Pre-tax Income | -74,808 | -31,833 | -34,532 | -25,492 | -18,124 |
| Net Income Continuous | -74,808 | -31,833 | -34,532 | -25,492 | -18,124 |
| Net Income | $-74,808 | $-31,833 | $-34,532 | $-25,492 | $-18,124 |
| EPS Basic Total Ops | -16.17 | -4.18 | -5.56 | -10.04 | -7.12 |
| EPS Basic Continuous Ops | -6.75 | -4.18 | -5.55 | -10.00 | -7.11 |
| EPS Diluted Total Ops | -16.17 | -4.18 | -5.56 | -10.04 | -7.12 |
| EPS Diluted Continuous Ops | -6.75 | -4.18 | -5.55 | -10.00 | -7.11 |
| EPS Diluted Before Non-Recurring Items | -16.08 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-81,479 | $-30,938 | $-34,930 | $-24,964 | $-18,223 |